Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas

UNC Libraries(2021)10.17615/0xsb-3v36Source: DataRank Database

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas is a research paper published in UNC Libraries (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: hybridTopics (19)IDs (PubMed)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

B. Grilley,H.E. Heslop,A.P. Gee,Barbara Savoldo ORCID,C.S. ROBERTSON

Live enrichment

PubMed:19162232

National Institutes of Health

Grant: 5P50CA126752-14

SPORE in Lymphoma

National Institutes of Health

Grant: 3P30CA125123-09S3

Baylor College of Medicine Cancer Center

hybridLicense: CC BY NC ND

https://doi.org/10.1016/j.ymthe.2018.09.009

http://www.cell.com/article/S1525001618304507/pdf

https://dx.doi.org/10.17615/0xsb-3v36

https://pubmed.ncbi.nlm.nih.gov/30309819

https://dx.doi.org/10.1016/j.ymthe.2018.09.009

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MaleReceptors, Chimeric AntigenLymphoma, Non-HodgkinT-LymphocytesAntigens, CD19Hematopoietic Stem Cell TransplantationReceptors, Antigen, T-CellMiddle AgedCombined Modality TherapyImmunotherapy, AdoptiveTransplantation, AutologousTreatment OutcomePositron Emission Tomography Computed TomographyHumansFemaleAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 14: 14. Life underwater